Summary
The detection and typing of tumor cells based on differentially or similarly expressed antigens (biomarkers) have proven to be increasingly important for the diagnosis and treatment of various cancers. Sensitive techniques for the detection of cell surface antigens are therefore crucial for the early and accurate detection of cancer. Although techniques such as ELISA and tissue staining have proven their worth, these techniques often either require substantial amounts of starting material or are prone to high background and false negatives. The proximity ligation assay (PLA) has proven to be an exquisitely sensitive technique with very low background. Two probes that bind adjacent to one another on a protein target can be ligated, yielding a unique amplicon that can be sensitively detected by real-time PCR. We have now adapted PLA to cell surface protein targets using modified RNA aptamers, and have shown that aptamer-based cell surface PLA can successfully detect and differentiate between cells that differentially express a tumor antigen, the prostate specific membrane antigen (PSMA).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Chu, T., Ebright, J., and Ellington, A. D. (2007) Using aptamers to identify and enter cells. Curr Opin Mol Ther. 9, 137–144
Jayasena, S. D. (1999) Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem. 45, 1628–1650
Lee, J. F., Stovall, G. M., and Ellington, A. D. (2006) Aptamer therapeutics advance. Curr Opin Chem Biol. 10, 282–289
Nimjee, S. M., Rusconi, C. P., and Sullenger, B. A. (2005) Aptamers: an emerging class of therapeutics. Annu Rev Med. 56, 555–583 5. Yan, A. C., Bell, K. M., Breeden, M. M., and Ellington, A. D. (2005) Aptamers: prospects in therapeutics and biomedicine. Front Biosci. 10, 1802–1827
Yan, A. C., Bell, K. M., Breeden, M. M., and Ellington, A. D. (2005) Aptamers: prospects in therapeutics and biomedicine. Front Biosci. 10, 1802–1827
Chu, T. C., Marks, J. W. III, Lavery, L. A., Faulkner, S., Rosenblum, M. G., Ellington, A. D., and Levy, M. (2006) Aptamer:toxin conjugates that specifically target prostate tumor cells. Cancer Res. 66, 5989–5992
Chu, T. C., Twu, K. Y., Ellington, A. D., and Levy, M. (2006) Aptamer mediated siRNA delivery. Nucleic Acids Res. 34, e73
Daniels, D. A., Chen, H., Hicke, B. J., Swiderek, K. M., and Gold, L. (2003) A tenascin-c aptamer identified by tumor cell selex: Systematic evolution of ligands by exponential enrichment. Proc Natl Acad Sci U S A. 100, 15416–15421
Hicke, B. J., Marion, C., Chang, Y. F., Gould, T., Lynott, C. K., Parma, D., Schmidt, P. G., and Warren, S. (2001) Tenascin-c aptamers are generated using tumor cells and purified protein. J Biol Chem. 276, 48644–48654
Shangguan, D., Li, Y., Tang, Z., Cao, Z. C., Chen, H. W., Mallikaratchy, P., Sefah, K., Yang, C. J., Tan, W. (2006) Aptamers evolved from live cells as effective molecular probes for cancer study. Proc Natl Acad Sci U S A. 103, 11838–11843
Fredriksson, S., Gullberg, M., Jarvius, J., Ols-son, C., Pietras, K., Gustafsdottir, S. M., Ost-man, A., and Landegren, U. (2002) Protein detection using proximity-dependent DNA ligation assays. Nat Biotechnol. 20, 473–477
Gullberg, M., Fr edriksson, S., Taussig, M., Jar vius, J., Gustafsdottir, S., Landegren, U. (2003) A sense of closeness: protein detection by proximity ligation. Curr Opin Biotechnol. 14, 82–86
Gullberg, M., Gustafsdottir, S. M., Schall-meiner, E., Jarvius, J., Bjarnegard, M., Bet-sholtz, C., Landegren, U., and Fredriksson, S. (2004) Cytokine detection by antibody-based proximity ligation. Proc Natl Acad Sci U S A. 101, 8420–8424
Gustafsdottir, S. M., Schallmeiner, E., Fredriks-son, S., Gullberg, M., Soderberg, O., Jarvius, M., Jarvius, J., Howell, M., and Landegren, U. (2005) Proximity ligation assays for sensitive and specific protein analyses. Anal Biochem. 345, 2–9
Schallmeiner, E., Oksanen, E., Ericsson, O., Spangberg, L., Eriksson, S., Stenman, U. H., Pettersson, K., and Landegren, U. (2007) Sensitive protein detection via triple-binder proximity ligation assays. Nat Methods. 4, 135–137
Zhu, L., Koistinen, H., Wu, P., Narvanen, A., Schallmeiner, E., Fredriksson, S., Landegren, U., and Stenman, U. H. (2006) A sensitive proximity ligation assay for active PSA. Biol Chem. 387, 769–772
Pai, S., Ellington, A. D., and Levy, M. (2005) Proximity ligation assays with peptide conjugate ‘burrs’ for the sensitive detection of spores. Nucleic Acids Res. 33, e162
Lupold, S. E., Hicke, B. J., Lin, Y., and Cof-fey, D. S. (2002) Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res. 62, 4029–4033
Padilla, R., and Sousa, R. (1999) Efficient synthesis of nucleic acids heavily modified with non-canonical ribose 2′-groups using a mutant T7 RNA polymerase (RNAP). Nucleic Acids Res. 27, 1561–1563
Chu, T. C., Shieh, F., Lavery, L. A., Levy, M., Richards-Kortum, R., Korgel, B. A., and Ellington, A. D. (2006) Labeling tumor cells with fluorescent nanocrystal-aptamer bio-conjugates. Biosens Bioelectron. 21, 1859–1866
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Pai, S.S., Ellington, A.D. (2008). Using RNA Aptamers and the Proximity Ligation Assay for the Detection of Cell Surface Antigens. In: Rasooly, A., Herold, K.E. (eds) Biosensors and Biodetection. Methods in Molecular Biology™, vol 504. Humana Press. https://doi.org/10.1007/978-1-60327-569-9_21
Download citation
DOI: https://doi.org/10.1007/978-1-60327-569-9_21
Publisher Name: Humana Press
Print ISBN: 978-1-60327-568-2
Online ISBN: 978-1-60327-569-9
eBook Packages: Springer Protocols